Article

FDA OKs therapeutic lenses, RGP solution

The FDA has approved the use of CIBA Vision's Focus NIGHT & DAY silicone hydrogel contact lenses for therapeutic use, and AOSEPT Clear Care lens-care solution for use with rigid gas permeable (RGP) contact lenses.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) Introducing iOpeners: Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
(Image credit: Ophthalmology Times) EyeCon 2025: Oluwatosin U. Smith, MD, previews a program of collaborative care and practical learning
Related Content
Surgical innovation in dry eye disease: Salivary gland transplant
August 28th 2025

Surgical innovation in dry eye disease: Salivary gland transplant

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
August 28th 2025

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Using opioids to prevent sneezing and potential ocular tissue damage during sedation and periocular injections
August 28th 2025

Using opioids to prevent sneezing and potential ocular tissue damage during sedation and periocular injections

Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures
August 28th 2025

(EyePod) From idea to impact: Navigating ophthalmic innovation

(Image credit: Ophthalmology Times) From firsts to the future: A pioneer's perspective on ophthalmology
August 28th 2025

From firsts to the future: A pioneer's perspective on ophthalmology

(Image credit: AdobeStock/InkInvent) FDA clears path for US IDE study of Myra Vision’s titratable glaucoma therapy
August 28th 2025

FDA clears path for US IDE study of Myra Vision’s titratable glaucoma therapy

© 2025 MJH Life Sciences

All rights reserved.